Protease-activated receptor 1: A role in prostate cancer metastasis

Ta Chun Yuan, Ming Fong Lin

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Protease-activated receptor (PAR) 1, PAR3, and PAR4 are considered "thrombin receptors" because thrombin specifically cleaves the extracellular N-termini of the receptor to unmask a new amino acid terminus, which in turn acts as a peptide ligand by binding intramolecularly to the body of the receptor. Among those 3 family members, PAR1 is the predominant thrombin receptor. Although the thrombin-mediated regulation of clot formation has been studied extensively over the past decades, the possible role of thrombin in tumor metastasis via PAR1 has only recently received attention and is briefly discussed herein.

Original languageEnglish (US)
Pages (from-to)189-191
Number of pages3
JournalClinical Prostate Cancer
Issue number3
StatePublished - Dec 2004


  • Angiogenesis
  • Cell adhesion
  • Cytoskeletal reorganization
  • G protein-coupled receptor
  • Mitogenesis
  • RhoA
  • Thrombin receptor activating peptide

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Protease-activated receptor 1: A role in prostate cancer metastasis'. Together they form a unique fingerprint.

Cite this